S. Korean firms reach US electric vehicle battery deal

Biden said in a statement that building electric vehicles and the batteries needed for them is an important part of his $2.3 trillion infrastructure plan. (Shutterstock)
Short Url
Updated 12 April 2021
Follow

S. Korean firms reach US electric vehicle battery deal

  • Battery makers agree on $1.8bn settlement, aiding Biden’s EV push

WASHINGTON: Two big South Korean electric vehicle battery makers said on Sunday they have settled a long-running trade dispute that will allow one company to move ahead with plans to manufacture batteries in Georgia. President Joe Biden called it “a win for American workers and the American auto industry.”

The agreement between LG Energy Solution and SK Innovation ended the need for Biden to intervene. He had until Sunday night to make a decision, following a ruling in February by a trade commission.

The companies said in a joint statement that SK will provide LG Energy with a total of $1.8 billion and an undisclosed royalty. They agreed to withdraw all pending trade disputes in the US and South Korea and not assert new claims for 10 years.

“We have decided to settle and to compete in an amicable way, all for the future of the US and South Korean electric vehicle battery industries,” said Jun Kim, CEO and president of SK, and Jong Hyun Kim, CEO and president of LG Energy.

The companies pledged to work together to strengthen the EV battery supply chain in the US and support the Biden administration’s efforts to advance clean energy policies, including electric vehicles.

The US International Trade Commission had decided in February that SK stole 22 trade secrets from LG Energy, and that SK should be barred from importing, making or selling batteries in the US for 10 years.

The decision could have left Ford and Volkswagen scrambling for batteries as they both roll out additional electric vehicle models, a priority for the companies and for the Biden administration, as it moves to address climate change. SK has contracts to make batteries for an electric Ford F-150 pickup truck and an electric Volkswagen SUV.

The commission said SK could supply batteries to Ford Motor Co. for four years and to Volkswagen AG for two years. The decision had jeopardized a $2.6 billion battery factory that SK is building in Commerce, Georgia.

Democratic Sen. Jon Ossoff of Georgia, who at Biden’s request had started negotiations between two companies, said the settlement “has saved the battery plant in Commerce, Georgia, ensuring thousands of jobs, billions in future investment, and that Georgia will be a leader in electric vehicle battery production for years to come.’” US Trade Representative Katherine Tai said the deal “builds confidence” in the reliability and responsibility of the two companies as suppliers to the US auto industry.

With the agreement, the US now is “in a stronger position to drive innovation and growth of clean energy technology” envisioned in Biden’s infrastructure plan “while also respecting the rights of technology innovators at the heart of trade and manufacturing policy,” Tai said.

Biden said in a statement that building electric vehicles and the batteries needed for them is an important part of his $2.3 trillion infrastructure plan.


Saudi-French cooperation to localize veterinary vaccine manufacturing

Updated 16 sec ago
Follow

Saudi-French cooperation to localize veterinary vaccine manufacturing

RIYADH: In the presence of sector leaders, the National Livestock and Fisheries Development Program signed a memorandum of understanding with French company Ceva under the patronage of Minister of Environment, Water and Agriculture Abdulrahman bin Abdulmohsen Al-Fadhli, who also chairs the program’s board.

The agreement aims to localize vaccine manufacturing, transfer technology and technical expertise, and expand the industrial and commercial production of veterinary vaccines across the Kingdom.

According to the MoU, the two parties will work to achieve high efficiency in mass production scale-up and establish a clear path for sustainable commercial operation that meets the needs of the local and national market, as well as strengthen the biosecurity and food security system.

The MoU also includes the development and modernization of messenger RNA vaccine technologies, along with joint research and development of a Middle East Respiratory Syndrome vaccine for camels. This involves designing, evaluating, and developing vaccines specifically tailored to combat the virus.

The agreement also covers the development of a rabies vaccine and related solutions, as well as supporting national efforts to control the disease through vaccine provision, capacity building, and the implementation of integrated prevention strategies.

The collaboration between the program and Ceva aims to meet the needs of the poultry vaccine market in the Kingdom, currently estimated at around SR750 million ($199 million).

The company will work to cover approximately 30 percent of this market with an initial investment of around SR250 million.

With continued government support for poultry projects and increased production in the sector, the market is expected to grow at a rate exceeding 10 percent annually, reaching approximately SR1.25 billion by 2030.

The addition of the world’s leading poultry vaccine manufacturer to Biotech Park highlights the program’s key role in developing new industries within the livestock and fisheries sector.

It also highlights the program’s commitment to building international partnerships with global companies, organizations, research centers, and universities to support advanced biotechnology industries and attract high-quality investments. It also seeks to create new economic sectors based on biotechnology, enhance veterinary health security, and support the sustainable economic development of the livestock sector, as well as empower national and emerging companies and provide advanced research and industrial infrastructure.

This will solidify the Kingdom’s position as a global hub for biotechnology industries and the development of national capabilities.

Ceva is the first international partner to join Biotech Park, the future veterinary biotechnology city launched by the program in Dhurma Governorate. The city is the world’s first specialized and fully integrated hub for veterinary biotechnology, serving as a benchmark for sector development and a platform supporting markets across the Kingdom, the Gulf, the Middle East, Africa and beyond.

The signing of Ceva is a significant step, given its position as the world’s leading manufacturer of poultry vaccines and medicines, and one of the most prominent international companies in the field of biotechnology.

The MoU aims to localize the veterinary vaccine industry, ensuring its compatibility with the strains of poultry diseases prevalent in Saudi Arabia. This includes the transfer of technology and technical expertise from Ceva, along with the implementation of specialized training programs to guarantee that manufacturing facilities comply with international Good Manufacturing Practice standards.